Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing prevalence of hot drought across western North America since the 16th century.

Science advances·2024
Same author

Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services.

Archives of pathology & laboratory medicine·2022
Same author

Solvent detergent treated pooled plasma and reduction of allergic transfusion reactions.

Transfusion·2019
Same author

Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.

Transfusion·2018
Same author

Blood Product Utilization Among Trauma and Nontrauma Massive Transfusion Protocols at an Urban Academic Medical Center.

Anesthesia and analgesia·2017
Same author

Perfect storm: Therapeutic plasma exchange for a patient with thyroid storm.

Journal of clinical apheresis·2017
Same journal

Identifying blood deserts in Liberia: A geospatial analysis.

Transfusion·2026
Same journal

Clot contraction of whole blood diminishes during storage and can be restored by adding platelets.

Transfusion·2026
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

A comprehensive program to minimize platelet outdating.

Alice K Fuller1, Kristin M Uglik, Hayden G Braine

  • 1Department of Pathology, HATS Division, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA. fulleal@jhmi.edu

Transfusion
|February 10, 2011
PubMed
Summary
This summary is machine-generated.

Implementing a proactive inventory management system significantly reduced platelet (PLT) outdating from over 10% to approximately 1% annually. This approach ensured adequate PLT supply for patients while minimizing waste.

More Related Videos

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Area of Science:

  • Transfusion Medicine
  • Healthcare Management
  • Hematology

Background:

  • Platelet (PLT) transfusions are critical for managing bleeding disorders.
  • The 5-day shelf life of PLTs poses inventory challenges, leading to significant waste.
  • In 2006, over 10% of apheresis PLTs in the US expired, highlighting a need for better inventory control.

Purpose of the Study:

  • To present an institutional approach for anticipating PLT inventory needs.
  • To examine strategies for predicting and adjusting to changes in PLT usage.
  • To review annual PLT outdating rates over a decade.

Main Methods:

  • Developed an inventory management system based on patient census and historical usage data.
  • Implemented strategies to predict transfusion needs and identify usage trends.
  • Analyzed 10 years of annual outdating data (2000-2009).

Main Results:

  • Achieved an average annual PLT outdate rate of approximately 1% over the 10-year study period.
  • Successfully met all patient transfusion demands without inventory shortages.
  • Transfused 128,207 PLT units to 15,265 patients between 2000 and 2009.

Conclusions:

  • Minimizing PLT outdating requires a knowledgeable staff, comprehensive patient transfusion history, and strong supplier relationships.
  • A proactive, data-driven approach can significantly reduce waste and ensure product availability.
  • The implemented program successfully minimized PLT outdating for over a decade, supporting optimal patient care.